本レポートは、診断業界の幹部や、ダイナミックで急速に拡大するがん診断検査市場への多角化を計画している企業が、今後 5 年間の新たな機会を評価し、効果的なビジネス戦略を開発するのに役立つように設計されています。
本レポートでは、40 を超える腫瘍マーカーについての詳細な市場セグメンテーション分析と予測の提供、革新的な技術と製品を備えた主要なサプライヤーと最近の市場参入者の紹介、現在および新たなアッセイのレビュー、現在の機器のレビュー、新しい技術の評価、サプライヤーに具体的な機会と成長戦略の提供を可能にします。
研究者らが腫瘍の診断と治療における大きな技術的進歩に近づき、新たな特異抗原を発見し、病気の遺伝的基盤の謎を解明するにつれて、がん診断市場は爆発寸前となっています。今後 5 年間で、世界のがん診断市場は刺激的でダイナミックかつ急速に拡大する分野になることが予想されます。予想される技術的進歩により、遺伝的素因の決定、特定の腫瘍の検出、がん治療に対する生物学的反応のモニタリングのための多くの機会が生み出されるでしょう。高齢者人口の増加は、悪性腫瘍検査に対する需要の高まりと世界中での急速な市場の拡大をさらに複雑にするでしょう。
目次
Table of Contents
I. Introduction
II. Worldwide Market Overview
III. Major Product Development Opportunities
A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Worldwide Market and Technology Overview
A. Cancer Statistics and Etiology
1. Breast Cancer
2. Lung Cancer
3. Colon and Rectum Cancer
4. Prostate Cancer
5. Stomach Cancer
6. Leukemia
7. Lymphoma
8. Oral Cancer
9. Skin Cancer
10. Uterine Cancer
11. Ovarian Cancer
12. Bladder Cancer
B. Major Current and Emerging Cancer Diagnostic Tests
1. Introduction
2. Tumor Marker Classification
3. ACTH
4. Alpha-Fetoprotein (AFP)
5. Beta-2 Microglobulin
6. CA 15-3/27.29
7. CA 19-9
8. CA-125
9. Calcitonin
10. Carcinoembrionic Antigen (CEA)
11. Estrogen and Progesterone Receptors
12. Ferritin
13. Gastrin
14. Human Chorionic Gonadotropin (HCG)
15. Insulin
16. NSE
17. Occult Blood
18. PAP Smear/HPV
19. Prostatic Acid Phosphatase (PAP)
20. Prostate-Specific Antigen (PSA)
21. Squamous Cell Carcinoma Antigen (SCC)
22. T and B Lymphocytes
23. TdT
24. Thyroglobulin
25. Tissue Polypeptide Antigen (TPA)
26. Biochemical Tumor Markers
27. Oncogenes
- Abl/abl-bcr
- AIB1
- BCL-2
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP-17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PTI-1
- Ras
- Reg
- Sis
- Src and others
28. Polypeptide Growth Factors
- Basic Fibroblast Growth Factor
- Beta-TGF
- Cachectin (TNT)
- Calmodulin
- ECFR
- Nerve Growth Factor (NGF)
- Epidermal Growth Factor (EGF)
- Ornithine Decarboxylase
- Transferrin
- Transforming Growth Factor-Alpha
29. Ectopic Hormones
30. Colony Stimulating Factors
31. Lymphokines
- Alpha-Interferon
- B Cell Growth Factors
- B Cell Growth Factor (BCGF)
- Gamma-Interferon
- Interleukin-1 (IL-1)
- Macrophage Activating Factor
32. Immunohistochemical Stains
33. Emerging Tumor Markers
- N-Acetylglucosamine
- Actin
- Alpha-Actin
- Antineuronal Antibodies
- 7B2
- B72.3
- Bax
- BCD-F9
- BLCA-4
- Blood Group Antigens A,B,H
- CA 50
- CA 72-4/TAG-72
- CA 195
- CA-242
- CA-549
- CAM 26
- CAR-3
- Cathepsin-D
- Chromogranin A and B
- Cluster 1 Antigen
- Cluster-5/5A Antigen
- CTA
- CU18
- DR-70
- DU-PAN-2
- Endometrial Bleeding Associated Factor
- Endostatin
- Epithelial Membrane Antigen
- Feulgen Hydrolysis
- Fibronectin
- FSH
- (1->3)-L-fucosyltransferase
- Gastrin-Releasing Peptide (GRP)
- GDCFP-15
- Glucagon
- Glycoamines
- H23
- Her-2
- Human Carcinoma Antigen
- HPA
- HSP27
- Intermediate Filaments
- Cytokeratins/CK18/Cyfra 21-1
- Desmin
- Gliofibrillary Acid Protein
- Neurofilaments
- Vimentin
- KA 93
- Kinases
- KP16D3
- LAI
- Leukocyte Common Antigen
- Lewis Antigens
- Lysophosphatidic Acid (LPA)
- Ma 695/Ma 552
- MABDF3
- MAG
- ME1
- Minactivin
- MN/CA9
- MSA
- Mucin Cancer Antigen (MCA)
- Multiple Tumor Suppressor 1
- Myosin
- NEA-130
- NMP22
- OA-519
- Opioid Peptides
- P-glycoprotein
- Pancreatic Oncofetal Antigen (POA)
- Placental Lactogen
- PR92
- Proliferative Index, Ki-67
- Px
- RB Inactivation/Deletion
- Ret
- SCCL 175
- Selectin
- Sialic Acid
- Sialyl SSEA-1/SLX
- SN10
- Somatostatin
- TA-90
- TABA
- Tachykinin
- TAG 12
- TPS
- Troponin
- Tubulin
- VCAM
- VEGF
- Villen and others
C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
D. Current and Emerging Cancer Diagnostic Technologies
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
3. Molecular Diagnostics
4. Chromosome Analysis
a. Chronic Myelogenous Leukemia (CML)
b. Acute Myeloid Leukemia (AML)
c. Acute Lymphoblastic Leukemia (ALL)
d. Malignant Lymphomas Lymphoid Malignancies
e. Chronic Lymphocytic Leukemia (CLL)
f. Solid Cancers
g. Chromosomal Translocation and Oncogenes
5. Artificial Intelligence
6. Flow Cytometry
7. Two Dimensional Gel Electrophoresis (2-DGE)
8. Biosensors
9. Competing/Complementing Technologies
E. Personal Testing
VIII. Country Market Analyses: Test Volume and Sales Forecasts, Supplier Shares
Canada
Mexico
U.S.A.
IX. Competitive Profiles
The report provides strategic assessments of over 30 leading cancer diagnostics market players and start-up companies with innovative technologies and products, including:
- Abbott
- Affymetrix
- Beckman Coulter/Danaher/Cepheid
- Becton Dickinson
- bioMerieux
- Bio-Rad
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Fujifilm Wako
- Grifols
- Hologic
- Leica Biosystems
- PerkinElmer
- Qiagen
- QuidelOrtho
- Roche
- Siemens Healthineers
- Takara Bio
- Thermo Fisher and others.
List of Tables
Canada Cancer Diagnostic Volume Forecasts by Test
Canada Cancer Diagnostics Sales Forecasts by Test
Mexico Cancer Diagnostic Volume Forecasts by Test
Mexico Cancer Diagnostics Sales Forecasts by Test
U.S.A. Executive Summary Table: Total Tumor
Marker Test Volume and Sales Forecast by Market Segment
U.S.A., Estimated New Cancer Cases and Deaths
U.S.A., Estimated Cancer Death Rates
Per 100,000 Population
U.S.A., Laboratories Performing Tumor
Marker Tests by Market Segment
U.S.A., Hospital Laboratories Performing
Tumor Marker Tests by Bed Size
U.S.A., Commercial/Private Laboratories
Performing Tumor Marker Tests by Annual Test Volume
U.S.A., Physician Office Laboratories
Performing Tumor Marker Tests by Practice Size
U.S.A., Total Tumor Marker Test Volume
Forecast by Market Segment
U.S.A., All Market Segments Major
Tumor Marker Test Volume Forecast
U.S.A., Hospital Laboratories Major Tumor
Marker Test Volume Forecast by Test
U.S.A., Commercial/Private Laboratories
Major Tumor Marker Test Volume Forecast
U.S.A., Physician Offices/Group Practices
Major Tumor Marker Test Volume Forecast
U.S.A., Cancer Clinics Major Tumor
Marker Test Volume Forecast by Test
U.S.A., Total Tumor Marker Sales
Forecast by Market Segment
U.S.A., All Market Segment Major Tumor
Marker Sales Forecast by Test
U.S.A., Hospital Laboratories Major Tumor
Marker Sales Forecast by Test
U.S.A., Commercial/Private Laboratories
Major Tumor Marker Sales Forecast by Test
U.S.A., Physician Offices/Group Practices
Major Tumor Marker Sales Forecast by Test
U.S.A., Cancer Clinics Major Tumor
Marker Sales Forecast by Test
U.S.A., ACTH Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., AFP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., CA 19-9 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., CA-125 Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Cathepsin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., CEA Test Volume and Diagnostics
Sales by Market Segment
U.S.A., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Colon-specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Ferritin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Gastrin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., HCG Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Insulin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., NSE Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Nucleolar Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Oncogenes Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Pancreatic Oncofetal Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., PAP Smear Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Parathyroid Hormone
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Progesterone Receptor
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., PAP Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., PSA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A., Serotonin Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Sialic Acid Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Squamous Cell Carcinoma Antigen
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., TDT Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Thymidine Kinase
Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Thyroglobulin Test
Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., TPA Test Volume and Diagnostics
Sales Forecast by Market Segment
U.S.A., Total Tumor Marker Sales by Major Supplier
U.S.A., ACTH Testing Market Diagnostics
Sales by Major Supplier
U.S.A., AFP Testing Market Diagnostics
Sales by Major Supplier
U.S.A., Beta-2 Migroblolulin Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CA 15-3/27.29 Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CA 19-9 Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CA 125 Testing Market
Diagnostics Sales by Major Supplier
U.S.A., CEA Testing Market
Diagnostics Sales by Major Supplier
U.S.A., Ferritin Testing Market
Diagnostics Sales by Major Supplier
U.S.A., HCG Testing Market
Diagnostics Sales by Major Supplier
U.S.A., Insulin Testing Market
Diagnostics Sales by Major Supplier
U.S.A., Parathyroid Hormone Testing Market
Diagnostics Sales by Major Supplier
U.S.A., PAP Testing Market Diagnostics
Sales by Major Supplier
U.S.A., Progesterone Receptor Testing Market
Diagnostics Sales by Major Supplier
U.S.A., PSA Testing Market Diagnostics
Sales by Major Supplier
Venezuela Cancer Diagnostic Volume Forecasts by Test
Venezuela Cancer Diagnostics Sales Forecasts by Test
Vietnam Cancer Diagnostic Volume Forecasts by Test
Vietnam Cancer Diagnostics Sales Forecasts by Test
Tumor Marker Classification
Major Companies Developing or
Marketing ACTH Tests
Major Companies Developing or
Marketing AFP Tests
Major Companies Developing or
Marketing Beta-2 Microglobulin Tests
Major Companies Developing or
Marketing CA 15-3/27.29 Tests
Major Companies Developing or
Marketing CA 19-9 Tests
Major Companies Developing or
Marketing CA 125 Tests
Major Companies Developing or
Marketing Calcitonin Tests
Major Companies Developing or
Marketing CEA Tests
Major Companies Developing or
Marketing Estrogen Receptor Tests
Major Companies Developing or
Marketing Progesterone Receptor Tests
Major Companies Developing or
Marketing Ferritin Tests
Major Companies Developing or
Marketing Gastrin Tests
Major Companies Developing or
Marketing HCG Tests
Major Companies Developing or
Marketing Insulin Tests
Major Companies Developing or
Marketing NSE Tests
Major Companies Developing or
Marketing Occult Blood Tests
Major Companies Developing or
Marketing PAP Smear/HPV Tests
Major Companies Developing or
Marketing PAP Tests
Major Companies Developing or
Marketing PSA Tests
Major Companies Developing or Marketing
Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or
Marketing Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications
in Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
